J&J warns diabetic patients: Insulin pump vulnerable to hacking
Why a lifesaving drug that's been around since 1923 is still unaffordable
Fast-acting, inhaled insulin Afrezza approved by F.D.A.
Johnson & Johnson Recalls Leaky Insulin Cartridges
As Diabetes Explodes, Big Pharma Is Gearing Up
Earnings Preview: Eli Lilly Expected to Report a Solid Quarter
Volunteers for clinical trials are essential -- when they enroll for the right reasons
Health reform and one man's struggle